Skip to main content
Defending AI, Machine Learning Patents in Life Sciences

Mintz Levin logo Defending AI, Machine Learning Patents in Life Sciences

Defending AI, Machine Learning Patents in Life Sciences

Even a decade after the US Supreme Court’s decision in Alice v. CLS Bank, patents continue to be invalidated under its two-part test for patent eligibility. Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon, explore this evolving landscape in a recent Law360 article. The attorneys focus on the implications for artificial intelligence and machine learning patents in the life sciences sector and share insights into navigating common pitfalls that have recently derailed AI/ML patents.

Learn More

Awards and Recognition

More from Mintz

Ready to Get Started?

Our Services